bioAffinity Technologies ... (BIAF)

0.26

-0.01 (-3.88%)

At close: Mar 28, 2025, 3:59 PM

0.27

3.70%

After-hours: Mar 28, 2025, 05:31 PM EDT

bioAffinity Cash Flow Statement

Table Mode

Year	FY23	FY22	FY21	FY20	FY19
Net Income	-7.94M	-8.15M	-6.33M	-7.27M	-3.31M
Depreciation & Amortization	249.59K	10.18K	4.82K	22.24K	40.28K
Stock-Based Compensation	748.82K	248.59K	43.01K	275.73K	n/a
Other Working Capital	603.92K	14.07K	593.8K	394.65K	361.54K
Other Non-Cash Items	n/a	3.71M	-244.35K	4.28M	575.11K
Deferred Income Tax	n/a	n/a	3.84M	n/a	n/a
Change in Working Capital	900.79K	114.2K	632.82K	482.62K	322.01K
Operating Cash Flow	-6.04M	-4.07M	-2.05M	-2.21M	-2.49M
Capital Expenditures	-22.9K	-219.99K	n/a	-2.89K	-11.4K
Acquisitions	-2.19M	n/a	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	n/a	n/a	n/a	n/a
Other Investing Acitivies	n/a	n/a	n/a	n/a	n/a
Investing Cash Flow	-2.21M	-219.99K	n/a	-2.89K	-11.4K
Debt Repayment	-344.98K	584.16K	212.26K	239.2K	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	n/a	7.73M	3.11M	1.48M	2.33M
Financial Cash Flow	-344.98K	14.34M	3.33M	1.72M	2.33M
Net Cash Flow	-8.59M	10.05M	1.28M	-495.38K	-166.59K
Free Cash Flow	-6.06M	-4.29M	-2.05M	-2.21M	-2.5M